Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Emergency Service, Hospital | 9 | 2018 | 221 | 1.440 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 6 | 2018 | 13 | 1.420 |
Why?
|
| Pulmonary Embolism | 6 | 2011 | 59 | 0.880 |
Why?
|
| Fibrinolytic Agents | 3 | 2018 | 57 | 0.700 |
Why?
|
| Venous Thromboembolism | 1 | 2018 | 37 | 0.600 |
Why?
|
| Colonoscopy | 3 | 2020 | 50 | 0.590 |
Why?
|
| Emergency Medicine | 4 | 2015 | 79 | 0.560 |
Why?
|
| Medical Overuse | 1 | 2015 | 6 | 0.530 |
Why?
|
| Health Policy | 1 | 2015 | 50 | 0.510 |
Why?
|
| Duodenal Diseases | 1 | 2013 | 6 | 0.450 |
Why?
|
| Vascular Fistula | 1 | 2013 | 4 | 0.450 |
Why?
|
| Intestinal Fistula | 1 | 2013 | 7 | 0.450 |
Why?
|
| Abdominal Pain | 1 | 2013 | 9 | 0.450 |
Why?
|
| Aorta, Thoracic | 1 | 2013 | 11 | 0.450 |
Why?
|
| Enema | 1 | 2010 | 3 | 0.360 |
Why?
|
| Polyethylene Glycols | 1 | 2010 | 58 | 0.340 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2010 | 79 | 0.330 |
Why?
|
| Critical Pathways | 1 | 2007 | 22 | 0.290 |
Why?
|
| Ischemic Attack, Transient | 1 | 2007 | 20 | 0.290 |
Why?
|
| Enterobius | 1 | 2006 | 1 | 0.270 |
Why?
|
| Enterobiasis | 1 | 2006 | 1 | 0.270 |
Why?
|
| Cecum | 1 | 2006 | 7 | 0.270 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2005 | 132 | 0.270 |
Why?
|
| Humans | 22 | 2020 | 29851 | 0.240 |
Why?
|
| Practice Guidelines as Topic | 1 | 2005 | 334 | 0.210 |
Why?
|
| Sensitivity and Specificity | 6 | 2009 | 558 | 0.200 |
Why?
|
| Health Services Research | 3 | 2015 | 42 | 0.190 |
Why?
|
| Endoscopy, Digestive System | 1 | 2020 | 9 | 0.180 |
Why?
|
| Gastroenterology | 1 | 2020 | 11 | 0.180 |
Why?
|
| Decision Support Techniques | 2 | 2018 | 51 | 0.180 |
Why?
|
| Age Factors | 3 | 2018 | 854 | 0.160 |
Why?
|
| Telephone | 1 | 1997 | 27 | 0.150 |
Why?
|
| Aftercare | 1 | 1997 | 23 | 0.150 |
Why?
|
| Evidence-Based Practice | 1 | 2018 | 77 | 0.150 |
Why?
|
| Male | 10 | 2020 | 15871 | 0.150 |
Why?
|
| Continuity of Patient Care | 1 | 1997 | 28 | 0.150 |
Why?
|
| Knowledge | 2 | 2007 | 19 | 0.150 |
Why?
|
| Feasibility Studies | 3 | 2020 | 230 | 0.150 |
Why?
|
| Diffusion of Innovation | 2 | 2007 | 38 | 0.150 |
Why?
|
| Adult | 5 | 2018 | 8748 | 0.130 |
Why?
|
| Clinical Decision-Making | 1 | 2015 | 38 | 0.130 |
Why?
|
| Environment | 1 | 2015 | 47 | 0.130 |
Why?
|
| Aged | 6 | 2013 | 9621 | 0.130 |
Why?
|
| Patient-Centered Care | 1 | 2015 | 61 | 0.130 |
Why?
|
| Diagnostic Imaging | 1 | 2015 | 90 | 0.120 |
Why?
|
| Risk Factors | 3 | 2018 | 2467 | 0.120 |
Why?
|
| Time Factors | 2 | 2015 | 1641 | 0.120 |
Why?
|
| Middle Aged | 7 | 2012 | 9963 | 0.120 |
Why?
|
| Risk Assessment | 3 | 2008 | 685 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2013 | 778 | 0.120 |
Why?
|
| Patient Care Team | 1 | 2015 | 141 | 0.120 |
Why?
|
| Prospective Studies | 4 | 2020 | 1824 | 0.110 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2013 | 10 | 0.110 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 399 | 0.100 |
Why?
|
| Headache | 1 | 2012 | 43 | 0.100 |
Why?
|
| Medicare | 1 | 2012 | 123 | 0.090 |
Why?
|
| Female | 8 | 2020 | 16430 | 0.090 |
Why?
|
| Colonic Diseases | 1 | 2010 | 12 | 0.090 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 232 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 456 | 0.080 |
Why?
|
| Resuscitation | 1 | 2008 | 18 | 0.080 |
Why?
|
| Antifibrinolytic Agents | 1 | 2009 | 23 | 0.080 |
Why?
|
| Cause of Death | 1 | 2008 | 64 | 0.080 |
Why?
|
| Program Evaluation | 2 | 2020 | 135 | 0.080 |
Why?
|
| Lower Extremity | 1 | 2008 | 38 | 0.080 |
Why?
|
| Hospital Mortality | 1 | 2008 | 140 | 0.080 |
Why?
|
| Information Dissemination | 1 | 2007 | 22 | 0.080 |
Why?
|
| Venous Thrombosis | 1 | 2008 | 42 | 0.070 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2007 | 10 | 0.070 |
Why?
|
| Protein Precursors | 1 | 2006 | 19 | 0.070 |
Why?
|
| Sepsis | 1 | 2008 | 147 | 0.070 |
Why?
|
| Calcitonin | 1 | 2006 | 15 | 0.070 |
Why?
|
| ROC Curve | 2 | 2008 | 140 | 0.070 |
Why?
|
| Surveys and Questionnaires | 2 | 2010 | 1187 | 0.070 |
Why?
|
| Recurrence | 1 | 2007 | 355 | 0.070 |
Why?
|
| Drug Therapy, Computer-Assisted | 1 | 2005 | 5 | 0.070 |
Why?
|
| Pilot Projects | 1 | 2007 | 403 | 0.070 |
Why?
|
| Heparin | 1 | 2005 | 27 | 0.070 |
Why?
|
| Bacteremia | 1 | 2006 | 117 | 0.070 |
Why?
|
| Pulmonary Artery | 1 | 2005 | 43 | 0.070 |
Why?
|
| Data Interpretation, Statistical | 1 | 2005 | 98 | 0.070 |
Why?
|
| Confidence Intervals | 1 | 2005 | 96 | 0.060 |
Why?
|
| Proportional Hazards Models | 1 | 2005 | 346 | 0.060 |
Why?
|
| Guideline Adherence | 1 | 2005 | 67 | 0.060 |
Why?
|
| Internship and Residency | 1 | 2007 | 213 | 0.060 |
Why?
|
| Nephelometry and Turbidimetry | 1 | 2003 | 1 | 0.060 |
Why?
|
| Stroke | 1 | 2007 | 294 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2010 | 3561 | 0.060 |
Why?
|
| Critical Illness | 1 | 2005 | 127 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2005 | 532 | 0.060 |
Why?
|
| Ambulatory Care | 1 | 2003 | 78 | 0.050 |
Why?
|
| Clinical Competence | 2 | 2020 | 230 | 0.050 |
Why?
|
| Hepatitis C, Chronic | 1 | 2001 | 80 | 0.040 |
Why?
|
| Learning Curve | 1 | 2020 | 18 | 0.040 |
Why?
|
| Accreditation | 1 | 2020 | 16 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2001 | 136 | 0.040 |
Why?
|
| Physicians | 1 | 2001 | 116 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2001 | 193 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2005 | 1953 | 0.040 |
Why?
|
| Peptic Ulcer | 1 | 1998 | 6 | 0.040 |
Why?
|
| Michigan | 1 | 1997 | 15 | 0.040 |
Why?
|
| Hospitals, Community | 1 | 1997 | 14 | 0.040 |
Why?
|
| Hospitals, Teaching | 1 | 1997 | 33 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2007 | 4930 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1998 | 107 | 0.040 |
Why?
|
| United States | 3 | 2012 | 2346 | 0.040 |
Why?
|
| Animals | 1 | 2006 | 4639 | 0.040 |
Why?
|
| Patient Education as Topic | 1 | 1997 | 161 | 0.030 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2015 | 4 | 0.030 |
Why?
|
| Interprofessional Relations | 1 | 2015 | 34 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 1997 | 297 | 0.030 |
Why?
|
| Communication | 1 | 2015 | 111 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 1997 | 507 | 0.030 |
Why?
|
| Neuroimaging | 1 | 2012 | 138 | 0.020 |
Why?
|
| Thrombolytic Therapy | 1 | 2011 | 55 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 803 | 0.020 |
Why?
|
| Angiography | 1 | 2009 | 39 | 0.020 |
Why?
|
| Observer Variation | 1 | 2008 | 119 | 0.020 |
Why?
|
| Shock, Septic | 1 | 2008 | 62 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2008 | 310 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2009 | 142 | 0.020 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2006 | 15 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2007 | 79 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 349 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2008 | 224 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2007 | 214 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2006 | 286 | 0.020 |
Why?
|
| Critical Care | 1 | 2008 | 242 | 0.020 |
Why?
|
| Prevalence | 1 | 2006 | 494 | 0.020 |
Why?
|
| Survival Rate | 1 | 2005 | 376 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 1126 | 0.020 |
Why?
|
| Radiography | 1 | 2005 | 678 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2012 | 3325 | 0.010 |
Why?
|
| Young Adult | 1 | 2009 | 1969 | 0.010 |
Why?
|
| Child | 1 | 2006 | 1379 | 0.010 |
Why?
|
| Brain | 1 | 2012 | 1727 | 0.010 |
Why?
|
| Liver Cirrhosis | 1 | 2001 | 60 | 0.010 |
Why?
|
| Data Collection | 1 | 2001 | 108 | 0.010 |
Why?
|
| Quality of Life | 1 | 2001 | 677 | 0.010 |
Why?
|